FXYD2 and nonpapillary renal cell carcinoma: RT-PCR (Figure 1(j)), IHC (Figure 1(k)) and WB (Figure 2(a)) analysis using our clinical tissue samples also verified the transcription and translation level of FXYD2 expression, which all showed downregulated expression of FXYD2 in ccRCC compared to the normal tissue.